Table 3.
Medical expenditures (in US dollars) during various post-operation periods for newly diagnosed ovarian cancer patients.
| N | Total | OOP | Insurance | COB | |||||
|---|---|---|---|---|---|---|---|---|---|
| Median | (IQR) | Median | (IQR) | Median | (IQR) | Median | (IQR) | ||
| Day of operation to 30 days post-operation | |||||||||
| Total | 5,031 | 30,501 | (21,623–44,167) | 777 | (190–1,905) | 26,783 | (14,970–39,797) | 0 | (0–0) |
| Inpatient services | 4,806 | 25,401 | (17,787–37,901) | 518 | (0–1,544) | 21,900 | (12,561–33,825) | 0 | (0–0) |
| Outpatient services | 4,873 | 4,213 | (1,410–8,379) | 59 | (5–230) | 3,077 | (728–7,746) | 0 | (0–0) |
| Outpatient drugs | 5,031 | 131 | (29–494) | 40 | (12–85) | 76 | (5–400) | 0 | (0–0) |
| 1 to 6 months post-operation | |||||||||
| Total | 5,031 | 38,795 | (22,737–62,762) | 837 | (351–1,903) | 33,595 | (13,929–60,029) | 0 | (0–0) |
| Inpatient services | 1,296 | 17,477 | (9,079–31,112) | 0 | (0–373) | 15,623 | (6,666–30,393) | 0 | (0–0) |
| Outpatient services | 5,030 | 32,105 | (18,538–50,573) | 523 | (155–1,446) | 27,916 | (10,549–48,535) | 0 | (0–0) |
| Outpatient drugs | 5,031 | 751 | (188–2,181) | 159 | (53–317) | 543 | (93–1,831) | 0 | (0–0) |
| 6 months to 1 year post-operation | |||||||||
| Total | 5,031 | 12,469 | (4,639–33,107) | 593 | (240–1,287) | 8,415 | (2,902–27,014) | 0 | (0–0) |
| Inpatient services | 944 | 20,592 | (10,768–39,778) | 0 | (0–479) | 14,362 | (3,669–31,963) | 0 | (0–0) |
| Outpatient services | 5,000 | 9,459 | (3,662–24,989) | 362 | (112–945) | 6,568 | (1,917–19,347) | 0 | (0–0) |
| Outpatient drugs | 5,031 | 450 | (84–1,486) | 111 | (25–267) | 302 | (31–1,159) | 0 | (0–0) |
The analyses of median and IQR were limited to the patients (N) who utilized the inpatient, outpatient services or outpatient drugs in each period. For each period, OOP (out-of-pocket), insurance liability, and COB (coordination of benefits and other savings) for inpatient, outpatient services and outpatient drugs were winsorized at 3rd & 97th percentiles, then summed to get inpatient, outpatient services, outpatient drugs, and total medical expenditures (including inpatient, outpatient services and outpatient drugs).